These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 34493600)
61. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms. Kojika M; Ishii G; Yoshida J; Nishimura M; Hishida T; Ota SJ; Murata Y; Nagai K; Ochiai A Mod Pathol; 2009 Oct; 22(10):1341-50. PubMed ID: 19648882 [TBL] [Abstract][Full Text] [Related]
62. [Thymoma and thymic carcinoma--review of literature and clinical characteristics based on the Polish Paediatric Solid Tumours Study Group experience]. Stachowicz-Stencel T; Bień E; Balcerska A; Godziński J; Madziara W; Perek-Polnik M; Peregud-Pogorzelski J; Pietras W; Pobudejska A; Kurylak A; Mańkowski P Med Wieku Rozwoj; 2007; 11(3 Pt 2):313-8. PubMed ID: 18663273 [TBL] [Abstract][Full Text] [Related]
64. Classification of thymoma by fine needle aspiration biopsy according to WHO classification: a cytological algorithm for stepwise analysis in the classification of thymoma. Ryu HS; Koh JS; Park S; Kim MS; Cho SY; Lee SS Acta Cytol; 2012; 56(5):487-94. PubMed ID: 23075888 [TBL] [Abstract][Full Text] [Related]
66. Zhao J; Zhao R; Xiang C; Shao J; Guo L; Han Y Front Oncol; 2021; 11():692283. PubMed ID: 34354947 [TBL] [Abstract][Full Text] [Related]
67. Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms. Pomplun S; Wotherspoon AC; Shah G; Goldstraw P; Ladas G; Nicholson AG Histopathology; 2002 Feb; 40(2):152-8. PubMed ID: 11952859 [TBL] [Abstract][Full Text] [Related]
68. Role of PAX-8, CD5, and CD117 in distinguishing thymic carcinoma from poorly differentiated lung carcinoma. Asirvatham JR; Esposito MJ; Bhuiya TA Appl Immunohistochem Mol Morphol; 2014; 22(5):372-6. PubMed ID: 23958552 [TBL] [Abstract][Full Text] [Related]
69. Hepatic metastasis of thymoma: case report and immunohistochemical study. Speisky D; de Davila MT; Vigovich F; Mendez J; Maurette R; Ejarque MG; Spina JC; Iotti A; Dezanzo P Ecancermedicalscience; 2016; 10():693. PubMed ID: 28101136 [TBL] [Abstract][Full Text] [Related]
70. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma. Pfister F; Hussain H; Belharazem D; Busch S; Simon-Keller K; Becker D; Pfister E; Rieker R; Ströbel P; Marx A Histopathology; 2017 Apr; 70(5):693-703. PubMed ID: 27791295 [TBL] [Abstract][Full Text] [Related]
71. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours. Pan CC; Chen PC; Wang LS; Lee JY; Chiang H Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732 [TBL] [Abstract][Full Text] [Related]
73. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma. Dorfman DM; Shahsafaei A; Miyauchi A Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728 [TBL] [Abstract][Full Text] [Related]
74. Thymic basaloid carcinoma: a clinicopathologic study of 12 cases, with a general discussion of basaloid carcinoma and its relationship with adenoid cystic carcinoma. Brown JG; Familiari U; Papotti M; Rosai J Am J Surg Pathol; 2009 Aug; 33(8):1113-24. PubMed ID: 19461509 [TBL] [Abstract][Full Text] [Related]
75. An immunohistochemical study of thymic epithelial tumors. I. Epithelial component. Kodama T; Watanabe S; Sato Y; Shimosato Y; Miyazawa N Am J Surg Pathol; 1986 Jan; 10(1):26-33. PubMed ID: 2420219 [TBL] [Abstract][Full Text] [Related]
76. [Clinicopathologic study of metaplastic thymoma]. Jin M; Liu B; Wang L; Xu JY Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):285-8. PubMed ID: 16777000 [TBL] [Abstract][Full Text] [Related]
77. [Expression of CD20 in thymomas and its clinical implication]. Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589 [TBL] [Abstract][Full Text] [Related]
78. Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Kirchner T; Schalke B; Buchwald J; Ritter M; Marx A; Müller-Hermelink HK Am J Surg Pathol; 1992 Dec; 16(12):1153-69. PubMed ID: 1463094 [TBL] [Abstract][Full Text] [Related]
79. Thymoma and thymic carcinoma in children and adolescents: a report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT). Stachowicz-Stencel T; Orbach D; Brecht I; Schneider D; Bien E; Synakiewicz A; Rod J; Ferrari A; Cecchetto G; Bisogno G Eur J Cancer; 2015 Nov; 51(16):2444-52. PubMed ID: 26259494 [TBL] [Abstract][Full Text] [Related]
80. Low-grade metaplastic carcinoma of the thymus. Yoneda S; Marx A; Heimann S; Shirakusa T; Kikuchi M; Müller-Hermelink HK Histopathology; 1999 Jul; 35(1):19-30. PubMed ID: 10383710 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]